Petition To US FDA For Using NMN In Supplements Reminds Agency Of Its Reversal On NAC

Natural Products Association and Alliance for Natural Health USA petition FDA to reconsider its stance on beta-nicotinamide mononucleotide. Excluding NMN from use in supplements “adversely affects the entire dietary supplement stakeholder community,” petition says.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation